Caray, Baby Girl .
HRN: 21-99-55 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/20/2022
CEFOTAXIME 500MG (VIAL)
11/20/2022
11/27/2022
IVTT
160mg
Q12
DIC
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes